The applicant's academic career demonstrates a longterm commitment to patientoriented research, extensive expertise in the study of the pathophysiology of age related cardiovascular disorders that disproportionately afflict older adults including heart failure with preserved systolic function and a successful record in mentoring residents, cardiology fellows and junior faculty in geriatrics and cardiology. The career plan of the applicant is to expand his research interests to multidisciplinary studies of age related cardiovascular conditions by focusing on heart failure with a normal ejection fraction, which accounts for more than half of the cases of heart failure in the United States and that afflicts predominately older adults. During the tenure of this award, the applicant will gain further training in genetics through formal coursework at the Mailman School of Public Health, strengthen existing and form new collaborative relationships with basic and clinical investigators at Columbia University, and institute a successful mentoring program for young clinical investigators from geriatrics and cardiology that will foster collaborative interdisciplinary investigations. The latter will be achieved by the creation of the Greater New York Geriatric Cardiology Consortium (GNYGCC) aimed at improving the care of older adult patients with cardiovascular disease by organizing and delivering a curriculum in geriatric cardiology as part of professional medical education activities and subsequently by performing innovative, investigatorinitiated, multicenter collaborative clinical investigation. The proposed mentoring program consists of three other components: 1) intensive individualized training in patientoriented research;2) Columbia University didactic programs on clinical trial design, data analysis, grant writing, and ethics;3) critical review by a team of patient oriented research experts. Awarding a Midcareer Investigator Award in PatientOriented Research will provide critically needed protected time to achieve these career goals. Columbia provides a strong institutional environment for support of the applicant's career development. The Department of Internal Medicine and Division of Cardiology have committed to protect e50% of the applicant's time for patientoriented research and mentoring. The proposed aims are to evaluate: (1) whether targeting anemia, one of many extracardiac factors that could contribute to the syndrome of HFNEF, is associated with improved ventricular function, functional capacity and health status. (2) for potential differences in pathophysiologic mechanisms that cause or contribute to anergia (lack of energy) in heart failure subjects stratified by a preserved or a reduced ejection fraction and (3) ventricular mechanics and functional capacity using use of noninvasive pressure volume analysis and actigraphy in older adults undergoing percutaneous aortic valve replacement. The proposed studies will advance applicant career development and provide a mechanism by which trainees can acquire the necessary skills to launch a research career and collect data to support grant applications. The ultimate goal is to facilitate the development of a new generation of investigators from both cardiology and geriatrics that can pursue clinical research in the arena of aging cardiovascular disease.
Cardiovascular Disease remains the leading cause of mortality in the United States with a majority of those afflicted being older adults. The broad goal of this program is to train the next generation of academic clinical cardiovascular investigators who will focus on cardiovascular disorders that disproportionately afflict older adults in order to improve the outcomes among these individuals.
|Maurer, Mathew S; Hanna, Mazen; Grogan, Martha et al. (2016) Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey). J Am Coll Cardiol 68:161-72|
|Cohen, Laura P; Maurer, Mathew S (2016) Letter by Cohen and Maurer Regarding Article, "Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis". Circulation 133:e449|
|Masterson Creber, Ruth M; Maurer, Mathew S; Reading, Meghan et al. (2016) Review and Analysis of Existing Mobile Phone Apps to Support Heart Failure Symptom Monitoring and Self-Care Management Using the Mobile Application Rating Scale (MARS). JMIR Mhealth Uhealth 4:e74|
|Brunjes, Danielle L; Castano, Adam; Clemons, Autumn et al. (2016) Transthyretin Cardiac Amyloidosis in Older Americans. J Card Fail 22:996-1003|
|Narotsky, David L; Castano, Adam; Weinsaft, Jonathan W et al. (2016) Wild-Type Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced Imaging. Can J Cardiol 32:1166.e1-1166.e10|
|Shah, Keyur B; Mankad, Anit K; Castano, Adam et al. (2016) Transthyretin Cardiac Amyloidosis in Black Americans. Circ Heart Fail 9:e002558|
|Cho, Younhee; Baranczak, Aleksandra; Helmke, Stephen et al. (2015) Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy). Amyloid 22:175-80|
|Wessler, Jeffrey D; Maurer, Mathew S; Hummel, Scott L (2015) Evaluating the safety and efficacy of sodium-restricted/Dietary Approaches to Stop Hypertension diet after acute decompensated heart failure hospitalization: design and rationale for the Geriatric OUt of hospital Randomized MEal Trial in Heart Failure (GO Am Heart J 169:342-348.e4|
|Shaffer, Jonathan A; Maurer, Mathew S (2015) Multiple Chronic Conditions and Heart Failure: Overlooking the Obvious? JACC Heart Fail 3:551-3|
|Tendler, Amanda; Helmke, Stephen; Teruya, Sergio et al. (2015) The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis. Amyloid 22:61-6|
Showing the most recent 10 out of 51 publications